Trademark: 79127322
Word
EPIGALLAT
Status Date
Monday, August 13, 2018
Filing Date
Friday, January 18, 2013
Abandoned Date
Monday, August 13, 2018
5 Pharmaceutical products, drugs for medical purposes, in particular for the treatment of cancers; enzyme preparations for medical purposes; dietetic substances for medical purposes, dietetic drinks for medical purposes, dietetic foods for medical purposes; nutritional supplements for medical purposes; mineral food-supplements; vitamin preparations; biological preparations for medical purposes; albumin preparations for medical purposes; chemical preparations for medical purposes; active biological nutritional supplements
Color is not claimed as a feature of the mark.
The transliteration of the non-Latin characters in the mark is: EPIGALLAT.
Mar 9, 2019
Notification Of Effect Of Cancellation Of Intl Reg Mailed
Mar 8, 2019
Death Of International Registration
Jan 23, 2015
Final Decision Transaction Processed By Ib
Dec 5, 2014
Final Disposition Notice Sent To Ib
Dec 5, 2014
Final Disposition Notice Created, To Be Sent To Ib
Sep 18, 2014
Notification Of Possible Opposition - Processed By Ib
Sep 3, 2014
Notification Of Possible Opposition Sent To Ib
Sep 3, 2014
Notification Of Possible Opposition Created, To Be Sent To Ib
Dec 6, 2013
Abandonment Notice Mailed - Failure To Respond
Dec 5, 2013
Abandonment - Failure To Respond Or Late Response
Jun 17, 2013
Change Of Owner Received From Ib
May 25, 2013
Refusal Processed By Ib
May 9, 2013
Non-Final Action Mailed - Refusal Sent To Ib
May 9, 2013
Refusal Processed By Mpu
May 9, 2013
Non-Final Action (Ib Refusal) Prepared For Review
May 8, 2013
Non-Final Action Written
May 8, 2013
Non-Final Action (Ib Refusal) Withdrawn For Review
May 8, 2013
Non-Final Action (Ib Refusal) Prepared For Review
May 7, 2013
Non-Final Action Written
May 2, 2013
Assigned To Examiner
Apr 6, 2013
Application Filing Receipt Mailed
Apr 2, 2013
New Application Office Supplied Data Entered In Tram
Mar 28, 2013
Sn Assigned For Sect 66a Subseq Desig From Ib
Trademark Alertz updated from USPTO on 2030-01-24
